Eduardo Salas Selected Research

LA 419

3/2007	The nitric oxide donor LA 419 decreases brain damage in a focal ischemia model.
2/2007	The nitric oxide donor LA 419 decreases ischemic brain damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eduardo Salas Research Topics

Disease

3	Tics (Tic) 07/2021 - 10/2014
3	Infections 03/2020 - 01/2017
2	Weight Loss (Weight Reduction) 10/2021 - 07/2019
2	Chronic Hepatitis B 03/2020 - 01/2018
2	Neoplasms (Cancer) 01/2018 - 09/2011
2	Stroke (Strokes) 01/2017 - 02/2007
2	Ischemia 03/2007 - 02/2007
2	Hypoxia (Hypoxemia) 03/2004 - 06/2003
1	Thrombophilia 07/2021
1	COVID-19 01/2021
1	Viremia 03/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2019
1	Epidermal Cyst (Sebaceous Cyst) 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Cardiac Arrhythmias (Arrythmia) 01/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Hemorrhagic Stroke 01/2017
1	Atrial Fibrillation 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Pain (Aches) 05/2015
1	Weight Gain 01/2015
1	Glucose Intolerance 01/2015
1	Obesity 01/2015
1	Genetic Risk Score 10/2014
1	Muscular Diseases (Myopathy) 01/2012
1	Vacuolar myopathy 01/2012
1	Breast Ductal Carcinoma 09/2011
1	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2011
1	Brain Ischemia (Cerebral Ischemia) 03/2007
1	Prostatic Neoplasms (Prostate Cancer) 03/2005
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2004
1	Acute Coronary Syndrome 03/2004
1	Thrombosis (Thrombus) 03/2004

Drug/Important Bio-Agent (IBA)

4	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2007 - 06/2003
2	Prothrombin (Factor II)IBA 07/2021 - 10/2014
2	Genetic Markers (Genetic Marker)IBA 01/2018 - 10/2014
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2012
2	LA 419IBA 03/2007 - 02/2007
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2004 - 06/2003
1	factor V LeidenIBA 07/2021
1	Peptides (Polypeptides)IBA 03/2020
1	Taurocholic Acid (Sodium Taurocholate)IBA 03/2020
1	Toll-Like Receptor 7IBA 01/2018
1	vesatolimodIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	vinyltriethoxysilane (VTES)IBA 01/2018
1	ElectrolytesIBA 01/2018
1	hepatitis B virus X proteinIBA 01/2017
1	pro-brain natriuretic peptide (1-76)IBA 01/2017
1	InterferonsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	CytokinesIBA 01/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	EndostatinsIBA 01/2017
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2015
1	LeptinIBA 01/2015
1	Blood Group Antigens (Blood Groups)IBA 10/2014
1	Chloroquine (Aralen)FDA LinkGeneric 01/2012
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2012
1	Colchicine FDA LinkGeneric 01/2012
1	AntioxidantsIBA 09/2011
1	Phenobarbital (Luminal)FDA Link 09/2011
1	Endothelin-1 (Endothelin 1)IBA 03/2007
1	Vasoconstrictor AgentsIBA 03/2007
1	Nitric Oxide DonorsIBA 03/2007
1	Biological ProductsIBA 03/2004
1	N- (N- gamma- L- glutamyl- 2- amino- 2- (4- (4- S- nitrosomercapto- 1- methylpiperidine)acetyl)glycine)IBA 03/2004
1	S-NitrosothiolsIBA 03/2004
1	NADPH Dehydrogenase (Dehydrogenase, NADP)IBA 03/2004
1	Proteins (Proteins, Gene)FDA Link 06/2003

Therapy/Procedure

2	Bariatric Surgery 10/2021 - 07/2019
2	Therapeutics 03/2020 - 05/2015
1	Personal Protective Equipment 01/2021
1	Endoscopes 01/2019
1	Renal Dialysis (Hemodialysis) 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Orchiectomy (Orchidectomy) 03/2005